Our findings revealed that these lncRNAs play a role in enhancing mitochondrial function by modulating cell cycle regulators such as WEE1 and CDK1/CYCLIN B1, which switch on oxidative fatty acid metabolism in the liver during the progression of MASLD. Here, CCNB1 is linked to metabolic dysfunction-associated steatotic liver disease.